be used to introduce not only the capacity to grow rapidly in eggs, which the manufacturer needs, but also the property of attenLuation for man2-or immunizing without producing influenza-which the patient wants.
The whole question of how a vaccine protects is also being reassessed. There has been much debate on whether old strains in a vaccine could confer a broad immunity, but it is now generally agreed that only current strains are of value, so that one each of influenza A and B are used. But it has recently become clear that the two components of the cell surface, the haemagglutinin (HA) and neuraminidase (N) , are separate chemically and immunologically,3 each being composed of distinct polypeptides. These ideas underly the new nomenclature for influenza A viruses.4 For instance, instead of "A2 Asian" we now have H2N2 and for "A2 Hong Kong" we have "HN2." These terms indicate that the new strains have a neuraminidase which is antigenically rather close to the old one, though the haemagglutinin is entirely different. Other laboratory work, also based in Kilbourne's laboratory and also using recombinants, has suggested that, though antibody against N does not inactivate the virus at all efficiently, it reduces the amount of disease and of virus shedding in mice.5 6 And it has recently been possible to protect chickens against chicken influenza by vaccinating them against the virus enzyme only.7
The question arises, Do these results apply to man? and two recent studies suggest that they do at least to some extent. At the time of arrival of H3N2 virus many people were carrying anti-N2 antibody, and some volunteers who had no anti-H, antibody nevertheless resisted infection with H3N2. So we can ask: Are anti-N2 antibody and resistance connected? A group of volunteers infected with influenza at the National Institutes of Health, Bethesda, Maryland, have been studied,8 and it was found that though they were almost all infected-they were given a large dose of rather virulent FLN2 virus-those with anti-N antibody were less ill and shed less virus than those without it. Similarly a group of British volunteers9 were studied by means of an attenuated influenza infection. With them too resistance to infection as determined in the laboratory was shown to be correlated with the presence of anti-N2 antibody in the circulation and to a slight extent with the same antibody in nasal secretions.
It is now possible to make vaccines containing any desired enzyme, and it may soon be possible 'to use purified haemagglutinin and neuraminidase preparations without the nucleic acid, the virus protein, and the traces of host material inevitably included with a whole-virus vaccine. Kilbourne has suggested that after vaccination against N a natural infection would be mild and resemble vaccination with a live vaccine.10 Others think that a pure HA antigen would be better, since it would probably induce neutralizing antibody and would protect solidly, but more work is needed to find which view is right. It is good to know that the study of influenza vaccines is alive with new ideas and that improved vaccines can be expected.
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Chronic Gastric Ulcers
A chronic gastric ulcer poses two questions to the clinician. Is it benign? Will it heal and stay healed with medical treatment? The main purpose of a study mounted at 16 Veterans Administration Hospitals in the United States was to find answers to these two questions. The report of the study, which concerned the period 1960-8, has recently been published.' The patients were males in whom a radiologist had reported the presence of a gastric ulcer on a barium meal. They were admitted to hospital for three weeks and given medical treatment of rest, milk or antacid every half hour, bland meat-free diet, anticholinergic drugs unless contraindicated, and sedative drugs and vitamins as required. Carbenoxylone was not used. The barium meal was repeated at three weeks, six weeks, and 12 weeks. The ulcer was expected to have been reduced in size 50% at three weeks, 90% at six weeks, and to have healed completely by 12 weeks. If healing was not satisfactory as judged by these time criteria, the patients were randomized between continued medical treatment and surgery.
Excluded from this study were certain types of gastric ulcer: those found at gastroscopy only and not on a barium meal (small acute ulcers); those in patients on corticosteroids, corticotrophin, or phenylbutazone (drug-induced ulcers); those in patients who had recently had major surgery, trauma, or burns (stress ulcers); those requiring urgent surgery for haemorrhage, perforation, or obstruction; and those in patients who had had previous gastric surgery. Six hundred and thirty-eight patients fulfilled the criteria for admission to the study and completed the 12-week period of treatment and were then followed up two years later.
In 46%, almost one-half, the healing was complete at the end of three weeks. In 70% healing was complete by six weeks, and in 76% it was complete by twelve weeks. There was no relationship between the location of the ulcer within the stomach and the likelihood of healing. Large ulcers required longer to heal than small ulcers. Co-existent duodenal ulcer or scarred duodenum, which was present in 42% of the series, did not affect the rate of healing. In patients with multiple gastric ulcers there was a greater chance that one of the ulcers would not heal satisfactorily.
Of the ulcers that healed two-fifths (42%) recurred. Recurrence was unaffected by the size or location of the ulcer or age of the patient. Most of the recurrences were observed within six months. A second recurrent ulcer developed in two-fifths of those whose first recurrent ulcer healed satisfactorily. There was a slightly higher incidence of recurrence in vatients with an associated duodenal ulcer.
In 111 patients the ulcer did not heal satisfactorily and they were randomized to receive medical or surgical treatment. Of those treated medically at this point only 58%
healed satisfactorily. Most of these had a recurrence in the ensuing two years, and only 24% were free of symptoms. Fortytwo patients had surgical treatments, and 71% of these had no recurrence or disabling postgastrectomy symptoms two years later. This was a better outcome after operation than in those treated medically. There was one postoperative death in the surgical group. The two groups were too small to allow a statistical comparison. But the figures do suggest that if the ulcer did not heal satisfactorily, as judged by the original criteria, most patients did better if they had surgery. In the whole series surgery was also necessary for haemorrhage, pyloric obstruction, and perforation in only a small proportion (4-3%).
Twenty-five patients (4% of the whole group) had gastric cancer. What is of importance clinically is that there was no relationship between the location of the ulcer in the stomach and the likelihood of malignancy, and not one of the 29 ulcers along the greater curvature was malignant. Large ulcers were five times more likely to be malignant than small ones. The chance of an ulcer being malignant was much less (one-fifth) if there was evidence of duodenal scarring or ulceration. In all but four of the patients the diagnosis was made in 12 weeks. In these four apparent healing of the ulcer occurred, and these cases are presented in detail. Certain little-known radiological signs "niche encastree," "niche en plateau," and "grosse niche triangulaire" are described and illustrated in the report. Gastroscopy did not help in the diagnosis of cancer in this study.
What does -this monumental study teach us? Firstly, in most patients with a chronic gastric ulcer healing will occur satisfactorily in three-quarters, but two-fifths of these will recur in two years. Carbenoxylone can, perhaps, improve the rate of healing, though not without danger to some patients. Does it improve the overall outcome? Secondly, in those that did not heal at a satisfactory rate, surgery, as opposed to continued medical treatment, led to a better final result for most patients. Finally, one in 25 of patients thought to have a benign lesion will have a cancer. This is unlikely if the patient has a small gastric ulcer or coexisting duodenal ulceration. There is no particular site in the stomach where it is liable to occur. It may even heal. It is in this area where the new flexible gastroscopes with biopsy attachment should be able to prove their worth.
International Medical History Congress in London
Last week in London, from 2 to 9 September, the International Society of the History of Medicine held its twentythird Congress. This society was founded in 1920 and its first congress was held in Belgium in that year. The third Congress was held in London exactly fifty years ago under the presidency of that great medical historian, the late Dr. Charles Singer, with Dr. J. D. Rolleston as general secretary. In 1922 a total of 150 delegates attended, representing some 16 countries. Last week 48 countries were represented by over 600 delegates, and no fewer than 268 papers were registered.
Fifty years ago Great Britain could boast of only one society devoted to medical history-namely, the Section of The congress adopted five main themes: the relations between British medicine and medicine in other countries; medicine and society (which included a special symposium on "The History of Provision for Health and Welfare"); clinical medicine (including a symposium on "Some Concepts of Clinical Medicine"); the history of dentistry; and medicine and the humanities. The symposium entitled "Some Concepts of Clinical Medicine" produced a fine historical survey of disease and its theories from prehistoric and magical medicine, through the times of , to modern genetic concepts. A paper by Dr. A. Bearn, of the Cornell Medical Centre in New York, traced the origins of genetic ideas in the work of Francis Galton (1822 Galton ( -1911 and in the approach of Archibald Garrod (1857 Garrod ( -1936 , whose classic work Inborn Errors of Metabolism (1909) showed the fundamental truth that errant variations in the chemical constituents of the body are the underlying cause of many recessively inherited diseases.
Many papers presented the relationship between British medicine and medicine elsewhere-and in particular the development of social medicine and public health in Britain, and their influence in other parts of the world. It was shown that individual doctors, and medical schools too, had carried the tradition of British medicine far and wide-from the presence of John Hunter in Portugal to the influence of the Edinburgh School on medicine in New Zealand. Scrupulous primary research was evident in many of these papers, as was also the case in several papers reassessing the theories and the history of the origins of a number of infectious diseases. Fortunately, the papers read at the congress will be published in due course, and this will enable them to be savoured again.
A stimulating social and visiting programme had been arranged, which included a medical tour of London, journeys to Oxford and Cambridge, and the royal colleges, whose medical treasures were on display. Many visitors must have been impressed with the care and thoughtfulness of all the arrangements and it was encouraging to see that, despite the expense of attending such a congress, several medical students had given up their holiday to cross the Atlantic and attend it.
